Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, 6 Traian Vuia Street, District 2, 020956 Bucharest, Romania.
Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 8 Eroii Sanitari Boulevard, District 5, 050474 Bucharest, Romania.
Molecules. 2022 Dec 9;27(24):8719. doi: 10.3390/molecules27248719.
Due to the structure of acylhydrazones both by the pharmacophore -CO-NH-N= group and by the different substituents present in the molecules of compounds of this class, various pharmacological activities were reported, including antitumor, antimicrobial, antiviral, antiparasitic, anti-inflammatory, immunomodulatory, antiedematous, antiglaucomatous, antidiabetic, antioxidant, and actions on the central nervous system and on the cardiovascular system. This fragment is found in the structure of several drugs used in the therapy of some diseases that are at the top of public health problems, like microbial infections and cardiovascular diseases. Moreover, the acylhydrazone moiety is present in the structure of some compounds with possible applications in the treatment of other different pathologies, such as schizophrenia, Parkinson's disease, Alzheimer's disease, and Huntington's disease. Considering these aspects, we consider that a study of the literature data regarding the structural and biological properties of these compounds is useful.
由于酰腙的结构同时具有药效团 -CO-NH-N= 基团和分子中存在的不同取代基,因此报道了各种药理学活性,包括抗肿瘤、抗菌、抗病毒、抗寄生虫、抗炎、免疫调节、抗水肿、抗青光眼、抗糖尿病、抗氧化以及对中枢神经系统和心血管系统的作用。这个片段存在于几种用于治疗某些疾病的药物的结构中,这些疾病是公共卫生问题的重中之重,如微生物感染和心血管疾病。此外,酰腙部分存在于一些可能用于治疗其他不同疾病的化合物的结构中,如精神分裂症、帕金森病、阿尔茨海默病和亨廷顿病。考虑到这些方面,我们认为研究这些化合物的结构和生物性质的文献数据是有用的。
Molecules. 2022-12-9
J Ethnopharmacol. 2021-3-25
Neuropsychopharmacology. 1987-12
ACS Chem Neurosci. 2017-9-15
Eur J Med Chem. 2019-11-26
Curr Pharm Biotechnol. 2018
Curr Top Med Chem. 2016
Acta Crystallogr E Crystallogr Commun. 2025-7-29
RSC Med Chem. 2025-7-1
Pharmaceuticals (Basel). 2025-6-18
Acta Crystallogr E Crystallogr Commun. 2025-5-13
Molecules. 2024-11-21
Beilstein J Org Chem. 2024-12-4
Biomed Pharmacother. 2020-1-6
Mini Rev Med Chem. 2020